HN2011001601A - Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica - Google Patents

Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica

Info

Publication number
HN2011001601A
HN2011001601A HN2011001601A HN2011001601A HN2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A HN 2011001601 A HN2011001601 A HN 2011001601A
Authority
HN
Honduras
Prior art keywords
morfina
therapeutics
derivatives
application
preparation
Prior art date
Application number
HN2011001601A
Other languages
English (en)
Inventor
Dlubala Alain
Ripoche Isabelle
Trecant Claier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of HN2011001601A publication Critical patent/HN2011001601A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTA INVENCION SE REFIERE A DERIVADOS DE MORFINA -6-GLUCORONIDO DE FORMULA I SIUIENTE EN LA R1 ES UN GRUPO HETEROAROMATICO DE 5 ESLABONES EVENTUALMENTE SUSTITUIDO CON UNO O VARIOS SUSTITUYENTES ELEGIDOS ENTRE ATOMOS DE HALOGENOS Y LOS GRUPOS ALQUILO (C1-C4) HALOGENO, HIDROXILO, HALOALQUILO (C1-C4), ALQUILOXI (C1-C4), ARIL-ALQUILO (C1-C4) Y ARILO, ESTANDO DICHO GRUPO ARILO EVENTUALMENTE SUSTITUIDO CON UNO O VARIOS GRUPOS ELEGIDOS ENTRE LOS GRUPOS ALQUILO (C1-C4), HALOALQUILO (C1-C4), HIDROXILO Y ALQUILO (C1-C4) EN FORMA DE BASE O SAL DE ADICION A UN ACIDO ASI COOM EN EL ESTADO DE HIDRATO O DE SOLVATO. LA PRESENTE INVENCION TIENE TAMBIEN POR OBJETO SU PROCEDIMIENTO DE PREPARACION Y SU APLICACION EN TERAPEUTICA.
HN2011001601A 2008-12-10 2011-06-09 Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica HN2011001601A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806949A FR2939437B1 (fr) 2008-12-10 2008-12-10 Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
HN2011001601A true HN2011001601A (es) 2013-09-16

Family

ID=41031604

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2011001601A HN2011001601A (es) 2008-12-10 2011-06-09 Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica

Country Status (30)

Country Link
US (1) US8461122B2 (es)
EP (1) EP2376512B1 (es)
JP (1) JP5616356B2 (es)
KR (1) KR20110104486A (es)
CN (1) CN102317301B (es)
AR (1) AR074514A1 (es)
AU (1) AU2009326909B2 (es)
BR (1) BRPI0922733A2 (es)
CA (1) CA2746429A1 (es)
CL (1) CL2011001399A1 (es)
CR (1) CR20110306A (es)
EA (1) EA019053B1 (es)
EC (1) ECSP11011110A (es)
ES (1) ES2468990T3 (es)
FR (1) FR2939437B1 (es)
HK (1) HK1163110A1 (es)
HN (1) HN2011001601A (es)
IL (1) IL213381A (es)
MA (1) MA32952B1 (es)
MX (1) MX2011006252A (es)
MY (1) MY152978A (es)
NI (1) NI201100115A (es)
NZ (1) NZ593344A (es)
PE (1) PE20120260A1 (es)
SG (1) SG172068A1 (es)
TN (1) TN2011000266A1 (es)
TW (1) TW201026312A (es)
UA (1) UA104302C2 (es)
WO (1) WO2010067010A2 (es)
ZA (1) ZA201104305B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103421063B (zh) * 2012-05-23 2016-04-06 宜昌人福药业有限责任公司 一种合成吗啡-6-β-D-葡萄糖醛酸苷的方法
CN111346104B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种吗啡-6-葡萄糖醛酸苷透皮给药的药物组合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
ES2201482T3 (es) * 1997-04-14 2004-03-16 Ufc Limited Derivados de la morfina.
HUP0102333A3 (en) 1998-06-06 2003-07-28 Cenes Ltd Cambridge Morphine-6-glucuronide synthesis
GB0218811D0 (en) * 2002-08-14 2002-09-18 Cenes Ltd Salts of morphine-6-glucuronide
FR2864082B1 (fr) * 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur
EP1758452B1 (en) * 2004-05-28 2017-01-25 Human Biomolecular Research Institute Metabolically stable analgesics and pain medications
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques

Also Published As

Publication number Publication date
PE20120260A1 (es) 2012-04-13
JP2012511553A (ja) 2012-05-24
NI201100115A (es) 2011-12-14
SG172068A1 (en) 2011-07-28
UA104302C2 (ru) 2014-01-27
IL213381A (en) 2014-02-27
HK1163110A1 (en) 2012-09-07
EA201170792A1 (ru) 2012-01-30
FR2939437B1 (fr) 2010-12-17
NZ593344A (en) 2013-08-30
WO2010067010A3 (fr) 2011-06-30
MA32952B1 (fr) 2012-01-02
WO2010067010A2 (fr) 2010-06-17
CN102317301B (zh) 2015-08-26
EA019053B1 (ru) 2013-12-30
TW201026312A (en) 2010-07-16
TN2011000266A1 (fr) 2012-12-17
CN102317301A (zh) 2012-01-11
MX2011006252A (es) 2011-11-04
CR20110306A (es) 2011-09-21
ZA201104305B (en) 2012-10-31
EP2376512B1 (fr) 2014-02-26
IL213381A0 (en) 2011-07-31
US20110301107A1 (en) 2011-12-08
AU2009326909B2 (en) 2016-05-26
JP5616356B2 (ja) 2014-10-29
EP2376512A2 (fr) 2011-10-19
MY152978A (en) 2014-12-15
ES2468990T3 (es) 2014-06-17
KR20110104486A (ko) 2011-09-22
ECSP11011110A (es) 2011-07-29
AR074514A1 (es) 2011-01-19
CL2011001399A1 (es) 2011-10-28
US8461122B2 (en) 2013-06-11
FR2939437A1 (fr) 2010-06-11
AU2009326909A1 (en) 2011-06-30
BRPI0922733A2 (pt) 2016-01-05
CA2746429A1 (fr) 2010-06-17

Similar Documents

Publication Publication Date Title
UY32606A (es) Sulfonamidas nematocidas
CR20190168A (es) Compuestos de benzo[b]tiofeno como agonistas de sting
AR111811A2 (es) Compuestos derivados de 1,2,4-oxadiazol y composiciones para el control de nematodos
AR075084A1 (es) Metodo de preparacion de quinolinil -oxidifenil - ciclopropanodicarboxamidas e intermediarios correspondientes
PE20131343A1 (es) Derivados de acido benzoico
CL2009000650A1 (es) Compuestos derivados de amino-pirazina, inhibidores de cinasa-pi 3; composicion farmaceutica; y uso para el tratamiento de condiciones inflamatorias o alérgicas, tales como enfermedades respiratorias, artritis reumatoide, colitis ulcerativa, entre otras
DK1893587T3 (da) Fremgangsmåde til fremstilling af dihydroquinazoliner
CL2009000142A1 (es) Composicion liquida monocomponente con un contenido de fluor con respecto a la resina solida de 5 a 75% en peso para el tratamiento permanente de superficies de sustratos porosos y no porosos; procedimiento para la obtencion de composiciones que contienen fluor; y uso de dichas composiciones.
ECSP10010688A (es) Activadores de glucoquinasa
MX343596B (es) Sulfonamidas nematocidas.
ECSP12012161A (es) Compuestos en calidad de antagonistas de Bradiquinina-b1
BR112017008176A2 (pt) método de preparação do carbonato de ácido glicérico.
PE20140703A1 (es) Derivados de heteroarilo como moduladores de nachr alfa 7
AR078278A1 (es) Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro.
CL2018002674A1 (es) Una composición de componente único o múltiple para la producción de un hidrogel
UY29749A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparación, así como su uso como medicamentos
CO6331307A2 (es) Derivados de imidazo[1,2alfa]piridin-2-carboxamidas su preparacion y su aplicacion en terapeutica
CO6251235A2 (es) Compuestos derivados de azetidinas su preparacion y su aplicacion en terapeutica
BR112015031293A2 (pt) politiol, composição para materiais ópticos, material óptico, e, lente
AR070874A1 (es) Compuesto heterociclico fusionado, una composicion farmaceutica que lo comprende y su uso en el tratamiento del cancer.
HN2011001601A (es) Derivados de morfina -6-glucoronido, su preparacion y su aplicacion en terapeutica
EA201490360A1 (ru) Композиции, содержащие соли аминокислот
CO6612193A2 (es) Octasacàridos n-acilos activadores de los receptores de los fgf su preparación y su aplicación en terapéutica
CO6251292A2 (es) Nuevos derivados 7-sustituidos de 3-carboxi-oxadiacino-quinolonas, su preparacion y su aplicacion como antibacterianos.
CO6321242A2 (es) Compuestos de n-fenil-imidazo[1,2-alfa]piridin-2-carboxamidas su preparacion y su aplicacion en terapeutica